EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe

Marko J Kallio, Viktoriia Starokozhko, Eleonora Agricola, Manja Burggraf, Anne Heß, Wolfgang Ballensiefen, Wiebke Löbker, Yoana Nuevo, Anna M G Pasmooij iD, Peter G M Mol iD, STARS consortium

Clinical Pharmacology & Therapeutics · 2023-02 · 113 (2) · 349-359

DOI: 10.1002/cpt.2789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 21.11.2022. Verfasst von Marko J Kallio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Finnish Medicines Agency, Helsinki, Finland. Hauptthemen laut MEDLINE: Drug and Narcotic Control, Drug Discovery. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Important discoveries by academic drug developers hold the promise of bringing innovative treatments that address unmet medical needs to the market. However, the drug development process has proved to be challenging and demanding for academic researchers, and regulatory challenges are an important barrier to implementing academic findings in clinical practice. European regulators offer varying degrees of support services to help drug developers meet regulatory standards and requirements. “Strengthening Training of Academia in Regulatory Sciences and Supporting Regulatory Scientific Advice” (STARS) is a European Commission–funded consortium aiming to strengthen the training of academics in regulatory science and requirements. Here, we report the results of four surveys that investigated the awareness and utilization of support tools offered by European regulators and identified the regulatory challenges and support needs of researchers. The surveys targeted four main European stakeholders in academic medicines research: academic research groups (706 respondents), academic research centers (99), funding organizations (49), and regulators (22). The results show that while European regulators provide various regulatory support tools, less than half of the responding academic researchers were aware of these tools and many experienced challenges in reaching a sufficient level of regulatory knowledge. There was a general lack of understanding of the regulatory environment that was aggravated by poor communication between stakeholders. The results of this study form a foundation for an improved European medicines regulatory network, in which regulatory challenges faced by academia are tackled.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug and Narcotic ControlDrug DiscoveryHumansEuropeSurveys and Questionnaires

Autor:innen und Institutionen

  • Finnish Medicines Agency, Helsinki, Finland.
  • Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Italian Medicines Agency, Rome, Italy.
  • Paul Ehrlich Institute, Langen, Germany.
  • Federal Institute for Drugs and Medical Devices, Bonn, Germany.

ORCID-Profile: Anna M G Pasmooij, Peter G M Mol

Zitieren

APA

Kallio, M. J., Starokozhko, V., Agricola, E., Burggraf, M., Heß, A., Ballensiefen, W., Löbker, W., Nuevo, Y., Pasmooij, A. M. G., Mol, P. G. M., & STARS consortium (2023). Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe. Clinical Pharmacology & Therapeutics, 113(2), 349-359. https://doi.org/10.1002/cpt.2789

Vancouver

Kallio MJ, Starokozhko V, Agricola E, Burggraf M, Heß A, Ballensiefen W, et al. Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe. Clinical Pharmacology & Therapeutics. 2023;113(2):349-359. doi:10.1002/cpt.2789

BibTeX
@article{Kallio2023,
  author = {Kallio, Marko J and Starokozhko, Viktoriia and Agricola, Eleonora and Burggraf, Manja and Heß, Anne and Ballensiefen, Wolfgang and Löbker, Wiebke and Nuevo, Yoana and Pasmooij, Anna M G and Mol, Peter G M and STARS consortium, STARS consortium},
  title = {Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {113},
  number = {2},
  pages = {349--359},
  doi = {10.1002/cpt.2789}
}
Kostenlos starten →